Section Arrow
Quote
ADMA.NASDAQ
- ADMA Biologics
Quotes are at least 15-min delayed:2024/05/06 23:30 EDT
Last
 6.91
+0.1 (+1.47%)
Day High 
6.94 
Prev. Close
6.81 
1-M High
6.81 
Volume 
2.41M 
Bid
6.88
Ask
6.96
Day Low
6.76 
Open
6.9 
1-M Low
5.895 
Market Cap 
1.58B 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 6.55 
20-SMA 6.34 
50-SMA 6.18 
52-W High 6.94 
52-W Low 3.06 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.13/0.51
Enterprise Value
1.72B
Balance Sheet
Book Value Per Share
0.58
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
258.22M
Operating Revenue Per Share
0.90
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LYRALyra Therapeutics0.519-3.511-87.12%-- 
JAGXJaguar Health0.314-0.004-1.26%-- 
TCBPTC BioPharm (Holdings) plc1.43-0.03-2.05%-- 
GLYCGlycoMimetics0.3155-1.5145-82.76%-- 
DNAGinkgo Bioworks Holdings0.9881+0.0331+3.47%-- 
Quotes are at least 15-min delayed：2024/05/06 23:30 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and othersat risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions tocertain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.